:

69.
  • ,

    37 53.62%
  • 23 33.33%
  • ,

    9 13.04%
1 20 1234567891011 ...
1 10 193

: (Salofalk 1000mg gastro-resistant prolonged release granules)

  1. #1
      svetlyhok
    +()
    22.02.2009
    36
    1,760
    18

     (Salofalk 1000mg gastro-resistant prolonged release granules)

    5-.
    1000 (Salofalk 1000mg gastro-resistant prolonged release granules) sderoo (). .(, , ). - . - .

    1. NAME OF THE MEDICINAL PRODUCT
    Salofalk 1000mg gastro-resistant prolonged release granules
    2. QUALITATIVE AND QUANTITATIVE COMPOSITION
    Each sachet of Salofalk 1000mg granules contains 1000 mg mesalazine.
    Excipient:
    Each sachet of Salofalk 1000mg granules contains 2.0mg aspartame.
    For a full list of excipients, see section 6.1.
    3. PHARMACEUTICAL FORM
    Gastro-resistant prolonged release granules.
    Description: Stick-formed or round, greyish white granules.
    4. CLINICAL PARTICULARS
    4.1 Therapeutic indications
    For the treatment of acute episodes and the maintenance of remission of ulcerative colitis.
    4.2 Posology and method of administration
    Adults and elderly:
    For the treatment of acute episodes of ulcerative colitis:
    Once daily 3 sachets of Salofalk 500mg granules or 3 sachets of Salofalk 1000mg granules (equivalent to 1.5 3.0 g mesalazine daily) preferably to be taken in the morning according to the individual clinical necessities.
    It is also possible to take the prescribed daily dose in three divided doses (1 sachet of Salofalk 500mg granules three times daily, or 1 sachet of Salofalk 1000mg granules three times daily), if this is more convenient to the patient.
    For the maintenance of remission of ulcerative colitis:
    1 sachets of Salofalk 500mg granules three times daily (equivalent to 1.5 g mesalazine daily).
    Children below 6 years of age:
    Salofalk granules should not be used in children under 6 years of age because there is very limited experience with this age group.
    Children older than 6 years of age and adolescents:
    In acute attacks, depending on disease severity, 30-50 mg mesalazine/kg/day should be given once daily preferably in the morning or in 3 divided doses. For maintenance of remission, 15-30 mg mesalazine/kg/day may be given in 2 divided doses. It is generally recommended that half the adult dose may be given to children up to a body weight of 40 kg; and the normal adult dose to those above 40 kg.
    All patients:
    The contents of the sachets of Salofalk granules should not be chewed. The granules should be taken on the tongue and swallowed, without chewing, with plenty of liquid.
    Both in the treatment of acute inflammatory episodes and during long term treatment, Salofalk granules should be used on a regular basis and consistently in order to achieve the desired therapeutic effects.
    In general, an acute episode of ulcerative colitis subsides after 8-12 weeks; the dosage can then, in most patients, be reduced to the maintenance dose.
    http://emc.medicines.org.uk/printfri...companyid=1418
    svetlyhok; 17.05.2009 11:46.
    ,
       

  2. #2
      Egoistka
    19.10.2008
    ,
    35
    113

    . . , , - ?
       

  3. #3
      svetlyhok
    +()
    22.02.2009
    36
    1,760
    18

    Egoistka
    . . , , - ?
    - , . , gastro-resistant prolonged release (. - ) , . .
    ,
       

  4. #4

    10.11.2008
    ,
    32
    12,853
    70

    , . , -
    !
       

  5. #5
      Egoistka
    19.10.2008
    ,
    35
    113

    . , 3-4 . , , ,
       

  6. #6
      babay
    28.12.2008
    -
    44
    911

    -, . , - ( ), , , , , Lialda? , , , .
       

  7. #7
      svetlyhok
    +()
    22.02.2009
    36
    1,760
    18

    babay
    -, . , - ( ), , , , , Lialda? , , , .
    .
    ,
       

  8. #8
      sderoo
    24.02.2009
    42
    21

    3 1000. . 1 . ( ) .
       

  9. #9
      svetlyhok
    +()
    22.02.2009
    36
    1,760
    18

    sderoo
    3 1000. . 1 . ( ) .
    ....
    ,
       

  10. #10
      Egoistka
    19.10.2008
    ,
    35
    113

    . . , ?
       

,

: 1 (: 0 , : 1)

  •